Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Clinical trial NCT00862459 · COMPLETED

Trial details

NCT number: NCT00862459
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Diseases Spinal Cord Diseases

Start date: 2005-08-01
Primary completion: 2007-03-01
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.